Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MIF | P14174 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8950485 | 0.79 | ALDH1A1 (0.61) | EPHX1HIF1ACYP1A2ALDH1A1TRPA1 | |
| SCHEMBL8165540 | 0.78 | EPHX1 (0.52) | EPHX1HIF1ACYP1A2ALDH1A1 | |
| SCHEMBL8165536 | 0.78 | EPHX1 (0.52) | EPHX1HIF1ACYP1A2ALDH1A1 | |
| SCHEMBL2049555 | 0.76 | EPHX1 (0.67) | EPHX1HIF1ACYP1A2ALDH1A1 | |
| SCHEMBL19420504 | 0.72 | EPHX1 (0.61) | EPHX1HIF1ACYP1A2ALDH1A1 | |
| SCHEMBL6819476 | 0.72 | EPHX1 (0.61) | EPHX1HIF1ACYP1A2ALDH1A1 | |
| SCHEMBL15667923 | 0.72 | EPHX1 (1.00) | EPHX1HIF1ACYP1A2ALDH1A1 | |
| Dicyclohexylcarbodiimide SCHEMBL3173433 | 0.72 | EPHX1 (1.00) | EPHX1HIF1ACYP1A2ALDH1A1 | |
| SCHEMBL21986399 | 0.72 | EPHX1 (1.00) | EPHX1HIF1ACYP1A2ALDH1A1 | |
| Dicyclohexylcarbodiimide SCHEMBL303 | 0.72 | EPHX1 (1.00) | EPHX1HIF1ACYP1A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4622674-A1 | ENHANCING OLIGONUCLEOTIDE IMMUNOMODULATORY ACTIVITY THROUGH DIANOPHORE LONG-LASTING MODIFICATION: METHODS AND APPLICATIONS | SEGENA CORPORATION S.A. (UY) | 2025-10-01 | — | — | EP | disclosed |
| WO-2024110843-A1 | ENHANCING OLIGONUCLEOTIDE IMMUNOMODULATORY ACTIVITY THROUGH DIANOPHORE LONG-LASTING MODIFICATION: METHODS AND APPLICATIONS | SEGENA CORPORATION S.A. (UY) | 2024-05-30 | — | — | WO | disclosed |
| US-20070039732-A1 | Methods and compositions for improving hydrocarbon recovery by water flood intervention | BJ SERVICES COMPANY | 2007-02-22 | — | — | US | disclosed |
| WO-2006088603-A1 | SOLUBLE DIVERTING AGENTS | FAIRMOUNT MINERALS, LTD. (US) | 2006-08-24 | — | — | WO | disclosed |
| US-20060175059-A1 | Soluble deverting agents | FAIRMOUNT SANTROL INC. (F/K/A FAIRMOUNT MINERALS, LTD.) | 2006-08-10 | — | — | US | disclosed |
| US-20060065396-A1 | Compositions containing water control treatments and formation damage control additives, and methods for their use | BAKER HUGHES, A GE COMPANY, LLC | 2006-03-30 | — | — | US | disclosed |
| US-6096727-A | Method for treating wounds using modified hyaluronic acid crosslinked with biscarbodiimide | ANIKA THERAPEUTICS, INC. (US) | 2000-08-01 | — | — | US | disclosed |
| US-6013679-A | REACTING HYALURONIC ACID, OR A SALT, WITH A CARBODIIMIDE TO FORM A WATER INSOLUBLE GEL IN THE ABSENCE OF A NUCLEOPHILE AND A POLYANIONIC POLYSACCHRIDE, DRYING, COMPRESSING TO FORM WATER INSOLUBLE, BIOCOMPATIBLE GEL | ANIKA RESEARCH, INC. (US) | 2000-01-11 | — | — | US | disclosed |
| US-5502081-A | COMPOSITIONS FOR SURGICAL AIDS FORMED FROM REACTION OF CARBODIIMIDE WITH HYALURONIC ACID | RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1996-03-26 | — | — | US | disclosed |
| US-5356883-A | Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use | RESEARCH FOUNDATION OF STATE UNIVERSITY OF N.Y. (US) | 1994-10-18 | — | — | US | disclosed |
| WO-1994002517-A1 | WATER-INSOLUBLE DERIVATIVES OF HYALURONIC ACID AND THEIR METHODS OF PREPARATION AND USE | ANIKA RESEARCH, INC. (US) | 1994-02-03 | — | — | WO | disclosed |
| EP-0416250-A2 | N-acylurea and O-acylisourea derivatives of hyaluronic acid | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1991-03-13 | — | — | EP | disclosed |
| US-4992544-A | Intermediates for b-lactam antibiotics and b-lactamase inhibitor | UNIVERSITY OF NOTRE DAME DU LAC (US) | 1991-02-12 | — | — | US | disclosed |